Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications

Table 3 High prevalence of metabolic syndrome in patients with rheumatic diseases

				Metabolic syndrome prevalence, percentage
	Number	Mean age, years	Women, percentage	NCEP	WHO	NCEP	WHO
	Rheumatoid arthritis (RA)					Control
Karvounaris, et al. [62]	200	63	74	44	-	41	-
Chung, et al. [63]
Early RA	88	51	64	30	31	22	-
Established RA	66	59	73	42	42
Dessein, et al. [61]	74	56	86	-	19	-	-
	Systemic lupus erythematosus					Control
Chung, et al. [67]	102	40	91	29	32	20	11
Magadmi, et al. [66]	44	51	100	18	-	-	-
	Ankylosing spondylitis					Control
Malesci, et al. [68]	24	51	12	46	-	11	-

ISSN: 1478-6362